Interview with Chris Beaver (inVentiv Health Clinical) on the recent trends in sponsor requests and how the CRO relationship with Pharma/biotech is evolving

Drug development Interviews

We sat down with Chris Beaver (inVentiv Health Clinical) at the recent 8th EBF Open Meeting discussing the increase in requests for immuno oncology assays and how inVentiv differentiate themselves in a extremely competitive CRO environment. We also asked Chris if he believes the CRO and Pharma/biotech relationship is more blended than ever.